Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
about
Processing of damaged DNA ends for double-strand break repair in mammalian cellsGenome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.Knockdown of TFIIS by RNA silencing inhibits cancer cell proliferation and induces apoptosis.DNA topoisomerase I inhibition by camptothecin induces escape of RNA polymerase II from promoter-proximal pause site, antisense transcription and histone acetylation at the human HIF-1alpha gene locus.Cellular processing determinants for the activation of damage signals in response to topoisomerase I-linked DNA breakage.Spartan deficiency causes accumulation of Topoisomerase 1 cleavage complexes and tumorigenesis.Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.Transcription blockage by bulky end termini at single-strand breaks in the DNA template: differential effects of 5' and 3' adducts.Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages.NBS1 cooperates with homologous recombination to counteract chromosome breakage during replication.Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissuesCellular basis of antiproliferative and antitumor activity of the novel camptothecin derivative, gimatecan, in bladder carcinoma models.Mycoplasma fermentans inhibits the activity of cellular DNA topoisomerase I by activation of PARP1 and alters the efficacy of its anti-cancer inhibitorEffects of DNA and protein size on substrate cleavage by human tyrosyl-DNA phosphodiesterase 1.All tangled up: how cells direct, manage and exploit topoisomerase function.Repair synthesis step involving ERCC1-XPF participates in DNA repair of the Top1-DNA damage complex.Mechanism of heat stress-induced cellular senescence elucidates the exclusive vulnerability of early S-phase cells to mild genotoxic stress.Topoisomerase 1 Regulates Gene Expression in Neurons through Cleavage Complex-Dependent and -Independent Mechanisms.Detection of DNA-protein crosslinks (DPCs) by novel direct fluorescence labeling methods: distinct stabilities of aldehyde and radiation-induced DPCs.Repair of topoisomerase I-mediated DNA damage.ISG15 deregulates autophagy in genotoxin-treated ataxia telangiectasia cells.DNA-PK triggers histone ubiquitination and signaling in response to DNA double-strand breaks produced during the repair of transcription-blocking topoisomerase I lesions.Topoisomerase IIβ deficiency enhances camptothecin-induced apoptosis.CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing.A rapid and sensitive assay for DNA-protein covalent complexes in living cellsISG15 as a novel tumor biomarker for drug sensitivity.Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects.SUMO modification of DNA topoisomerase II: trying to get a CENse of it allActivation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblock.Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivityHyperphosphorylation of RNA polymerase II in response to topoisomerase I cleavage complexes and its association with transcription- and BRCA1-dependent degradation of topoisomerase I.Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3pProteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forks.The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 2: transcriptional regulationRepair of hydantoin lesions and their amine adducts in DNA by base and nucleotide excision repair.Mutagenic potential of DNA-peptide crosslinks mediated by acrolein-derived DNA adductsThe applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases.Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition.Mutant Cockayne syndrome group B protein inhibits repair of DNA topoisomerase I-DNA covalent complex.
P2860
Q28000148-1F67E287-1D18-434B-9752-6A645C57C172Q30497476-4D414BE6-3E90-49F2-990D-EC563838FB84Q33333952-422BEE18-9A8B-4726-A8C0-854B36E25496Q33566415-50B6DD63-6472-409F-9181-9548A57C1871Q33625720-43654E00-24BC-4D33-AEC9-006216CC3E9BQ33635959-E3B6355B-4ED8-474C-9B61-BA8CB569CF43Q33951823-BDD23334-1F1D-4B37-93E5-1DE446DDE3DAQ34127710-E93FAD86-E7C7-4456-B1AF-20D063D53224Q34312801-DEDF892E-172D-4BB2-9644-01EBBFA613A8Q34369400-6E34E49D-ADA3-4950-851B-72D9EB37DBC6Q34531543-5B8DCD36-8D35-4B11-824F-9FD7CBAD8B03Q34768288-F77A9A3B-C3BF-4823-B37B-85830134B2EEQ34980863-A085B316-4AB2-445B-8367-32458E88DE36Q35152316-EFCF94BF-1658-47E1-BD8D-B4A2B361EED4Q35154537-8680178C-FF73-4486-850E-87C94F022256Q35646857-E5D3E379-FC97-4646-983B-43E4897DB60AQ35885916-36303444-0C44-4A09-8918-D495A07436B7Q36032196-61E934B5-FF6F-493E-BD55-A382349AC43EQ36305588-33F648B6-1BBC-4B6C-89BD-DEA940285038Q36557533-ECD556C1-C745-4F14-B382-222288EBE093Q36561981-46E5B70D-D7EF-49E3-B9BF-685E49F2D088Q36588889-450AAA1A-D864-4C86-B7CA-FFE6E4F3F1F6Q36666233-96A765B3-62CC-48F1-9F2E-6DE781464865Q36802373-1E080061-BCE8-45F2-B03C-3247EFE15410Q36814199-F97532F1-0F0B-408A-B6BF-A4E62A62A0EFQ36922901-E7DEEDB2-F187-40E3-ADCF-E96DC10C8282Q37048164-E9DA4DE6-8552-407A-A9B2-3B1E1CE68472Q37207512-A294C556-E4FE-4853-A875-162499876DA0Q37264391-42046659-67F5-4C2E-B882-683911F86EB9Q37309374-6CD37C89-5C08-49D0-B1A8-352639002929Q37369481-573ED5CE-70D0-46EF-9580-2A793E9B59E8Q37418686-6FDC72AA-4896-4A66-8F14-61E501F158C6Q37459929-229DCBC0-CC67-44D3-8E59-A37C72FF6E22Q37517720-552AE400-7166-430C-BAB9-1957CBFFD342Q37532110-ECA8D44F-794D-4EF5-A577-95F8A62FC8BCQ38573535-A0F01231-050A-41BF-A6C5-FAA83E9C5F59Q38856091-3415F89C-82B4-4686-87F0-2F71875104B9Q39305667-55037D33-0F96-4134-8840-1D9CEC30C653Q39561547-2354521D-941A-49E8-BD19-2E817F1AC126Q39622327-7F1EAD3B-644C-40A0-9CBC-F458B403BF75
P2860
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
@ast
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
@en
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
@nl
type
label
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
@ast
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
@en
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
@nl
prefLabel
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
@ast
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
@en
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
@nl
P2093
P2860
P1476
Transcription-dependent degradation of topoisomerase I-DNA covalent complexes
@en
P2093
Alexandra Rodriguez-Bauman
Eric H Rubin
Jin-Ming Yang
Leroy F Liu
Murugesan K Gounder
Shyamal D Desai
Xiaohua Wu
P2860
P304
P356
10.1128/MCB.23.7.2341-2350.2003
P407
P577
2003-04-01T00:00:00Z